BioNTech SE - BNTX Company Short-Term Debt

Graphic logo of BioNTech SE (BNTX)

BioNTech SE generates revenue from the commercialization of mRNA drugs for the treatment of infections and oncology. Its substantial cash reserves ensure financial stability and the development of new projects. The company is currently converting its capital into the creation of cutting-edge anti-cancer drugs. Short-term liabilities help monitor liquidity risks, with the 0.16 value expressing the current liabilities metric.

BNTX (BioNTech Inc.) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

BioNTech Pharma - analytical breakdowns and key metrics (BNTX)

- price and consensus price forecast:
Price Chart BioNTech|BNTX - Fair Value Consensus
- market capitalization data:
Market Value BioNTech SE|BNTX - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share BioNTech|BNTX - Book Capitalization|Market Cap to Net Assets Ratio biontech.de|BNTX - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital BioNTech SE|BNTX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity BioNTech SE|BNTX - Company Total Debt|Debt to Book Capitalization Ratio BioNTech SE|BNTX - Company Long-Term Liabilities|Company Current Liabilities BioNTech
Fundamental company valuation:BioNTech - BNTX
Product sample of BioNTech SE

BioNTech SE (BNTX) ability to withstand a market downturn depends on the liquidity of its current liabilities. Maintaining sterile plants and expanding the global factory network require colossal capital expenditures. Short-term loan debt captures the amount of payments due for repayment or refinancing within the coming year. This indicator measures the risk of a cash gap in the event of a breach of loan covenants. The stability of this metric confirms the financial resilience of the operating model.

Competitor analysis

Company Short-Term Debt argenx (ARGX)|ABVX: Company Short-Term Loans and Borrowings|ADMA (ADMA Bio) - Company Short-Term Debt|Protagonist Corp (PTGX) - Company Current Liabilities|IMVT (Immunovant, Inc.) - Company Short-Term Debts|Company Short-Term Debts kiniksa.com (KNSA)|Grifols (GRFS) - Company Current Liabilities|Company Short-Term Loans and Borrowings Adaptive Biotech (ADPT)|Company Short-Term Debts CLDX|Aurinia Corp - Short-Term Debt Volume|BCRX: Company Short-Term Debt|VERA: Company Current Liabilities|DNTH (Dianthus Therapeutics, Inc.) - Company Short-Term Debt|Company Current Liabilities Pharvaris NV|ABCL (AbCellera Biologics) - Company Current Liabilities|Company Short-Term Debts TRML|Company Short-Term Debt Precigen, Inc. PGEN|Company Short-Term Indebtedness pharming.com (PHAR)|NKTR: Company Short-Term Debts|Short-Term Debt Upstream Bio, Inc. UPB|ZBIO - Company Short-Term Debts|IMNM - Company Short-Term Debt|Gossamer Bio, Inc. - Company Short-Term Debts|KALV (kalvista.com) - Short-Term Debt Volume|Company Short-Term Debt SEPN (Septerna)|Short-Term Debt PVLA|Company Short-Term Debt Savara Corp SVRA|Company Short-Term Indebtedness Rigel Corp RIGL|Company Current Liabilities AnaptysBio, Inc. (ANAB)|Amount of Current Liabilities astriatx.com ATXS|ENGN (enGene) - Company Short-Term Debts|RAPT - Short-Term Debt|JBIO (aerovatetx.com) - Company Short-Term Debts|Aclaris Therapeutics, Inc (ACRS) - Company Current Liabilities|KYTX - Company Short-Term Debts|Company Short-Term Loans and Borrowings tizianalifesciences.com (TLSA)|Cabaletta Bio (CABA) - Company Current Liabilities|Company Short-Term Loans and Borrowings VTYX (Ventyx Biosciences Inc.)|Company Short-Term Debt THTX|Short-Term Debt Volume Avalo Therapeutics Inc AVTX|ELDN (Eledon Pharmaceuticals) - Company Short-Term Debts|AGEN - Short-Term Debt|Climb Bio (CLYM) - Company Short-Term Debts|ZURA (zurabio.com) - Company Short-Term Debt|Company Short-Term Debt aTyr (ATYR)|Company Short-Term Indebtedness Adagene Corp (ADAG)|Company Current Liabilities ImageneBio Inc|Amount of Current Liabilities shattucklabs.com STTK|EQ - Company Current Liabilities|Connect Biopharma Holdings - Company Short-Term Indebtedness|Company Short-Term Debt Immunic Inc|ATRA - Current Liabilities|Company Short-Term Debts inflarx.de IFRX|x4pharma.com (XFOR) - Company Short-Term Loans and Borrowings|ACET (Adicet Bio Inc.) - Company Short-Term Debts|Company Short-Term Debts CELU|INmune Bio Corp (INMB) - Company Short-Term Debt|Company Short-Term Loans and Borrowings BRNS (Barinthus Biotherapeutics Corp)|Kezar Life Sciences - Company Short-Term Debt|Company Current Liabilities sabbiotherapeutics.com SABS|Akari Therapeutics Plc - Company Short-Term Debts|Enlivex Therapeutics (ENLV) - Company Short-Term Debts|Company Current Liabilities q32bio.com QTTB|GeoVax Corp (GOVX) - Company Short-Term Loans and Borrowings|EDSA: Company Short-Term Debts|Short-Term Debt Volume IBIO|Company Short-Term Debt CARM (Carisma Therapeutics)|Company Current Liabilities XTLB (XTL Biopharmaceuticals Ltd)|Bolt Biotherapeutics, Inc. - Company Short-Term Debt|HCWB - Company Current Liabilities|Aptevo - Company Current Liabilities|AIM: Company Short-Term Debts|Company Short-Term Debt aditxt.com|GRI Bio Inc (GRI) - Company Short-Term Indebtedness|Company Short-Term Debts XRTX (XORTX)|Short-Term Debt Vyome Therapeutics|Company Short-Term Debts Revelation Biosciences (REVB)|Company Short-Term Debt indaptusrx.com (INDP)|Company Short-Term Debts SCNI|CalciMedica Inc - Short-Term Debt Volume|AFMD (Affimed Therapeutics) - Company Short-Term Debt|ALLK: Short-Term Debt|Company Short-Term Debt hookipapharma.com|Company Short-Term Indebtedness IGM Biosciences|iTeos Therapeutics, Inc. (ITOS) - Company Current Liabilities|Amount of Current Liabilities Ocean Biomedical Inc|TC BioPharm (Holdings) PLC - Company Short-Term Debts|Short-Term Debt Third Harmonic Bio Inc (THRD)